Sentinel Lymph Node Biopsy in Vulvar Cancer: A Health Technology Assessment for the Canadian Health Care Context

Journal of Obstetrics and Gynaecology Canada

Volumn 34, Issue 11, 2012, Pages 1053-1065

  Reade, Clare J ^a,b   Jimenez, Waldo ^b   O'Reilly, Daria ^b   Covens, Al ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Health technology assessment; Lymphadenectomy; Lymphedema; Sentinel lymph node biopsy; Vulvar cancer

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EARLY CANCER; FALSE NEGATIVE RESULT; FEASIBILITY STUDY; FEMALE; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH TECHNOLOGY ASSESSMENT; HUMAN; LYMPH NODE DISSECTION; PATIENT SAFETY; PATIENT SELECTION; SENTINEL LYMPH NODE BIOPSY; VULVA CANCER; BIOMEDICAL TECHNOLOGY ASSESSMENT; CANADA; COST BENEFIT ANALYSIS; ECONOMICS; INGUINAL REGION; LABORATORY DIAGNOSIS; MEDICAL TECHNOLOGY; PATHOLOGY; REVIEW; TUMOR RECURRENCE; VULVA TUMOR;

BIOMEDICAL TECHNOLOGY; CANADA; COST-BENEFIT ANALYSIS; FALSE NEGATIVE REACTIONS; FEMALE; GROIN; HUMANS; LYMPH NODE EXCISION; NEOPLASM RECURRENCE, LOCAL; SENTINEL LYMPH NODE BIOPSY; TECHNOLOGY ASSESSMENT, BIOMEDICAL; VULVAR NEOPLASMS;

EID: 84879099585     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)35435-4     Document Type: Article

References (110)

1. WHO/ICO Information Centre on HPV and Cervical Cancer. Human papillomavirus and related cancers in Canada. Summary Report 2010. HPV information centre, editor 2010, WHO/ICO HPV Information Centre, Barcelona.
2. Judson PL H.E., Baxter N.N., Durham S.B., Virnig B.A. Trends in the incidence of invasive and in situ vulvar carcinoma. Obstet Gynecol 2006, 107(5):1018-1022.
3. Klint A., Tryggvadottir L., Bray F., Gislum M., Hakulinen T., Storm H.H., et al. Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010, 49(5):632-643.
4. Faught W., Jeffrey J., Bryson P., Dawson L., Helewa M., Kwon J., et al. Management of squamous cell cancer of the vulva. J Obstet Gynaecol Can 2006, 28(7):640-651.
5. Selman T.J., Luesley D.M., Acheson N., Khan K.S., Mann C.H. A systematic review of the accuracy of diagnostic tests for inguinal lymph node status in vulvar cancer. Gynecol Oncol 2005, 99(1):206-214.
6. Gaarenstroom K.N., Kenter G.G., Trimbos J.B., Agous I., Amant F., Peters A.A., et al. Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions. Int J Gynecol Cancer 2003, 13(4):522-527.
7. Pereira de Godoy J.M., Braile D.M., de Fatima Godoy M., Longo O. Quality of life and peripheral lymphedema. Lymphology 2002, 35(2):72-75.
8. El-Ghobashy A.E., Saidi S.A. Sentinel lymph node sampling in gynaecological cancers: techniques and clinical applications. Eur J Surg Oncol 2009, 35(7):675-685.
9. Mansel R.E., Fallowfield L., Kissin M., Goyal A., Newcombe R.G., Dixon J.M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 2006, 98(9):599-609.
10. Barton D.P.J., Berman C., Cavanagh D., Roberts W.S., Hoffman M.S., Fiorica J.V., et al. Lymphoscintigraphy in vulvar cancer: a pilot study. Gynecol Oncol 1992, 46(3):341-344.
11. de Hullu J.A., Piers D.A., Hollema H., Aalders J.G., van der Zee A.G. Sentinel lymph node detection in locally recurrent carcinoma of the vulva. BJOG 2001, 108(7):766-768.
12. Oonk M.H., van Hemel B.M., Hollema H., de Hullu J.A., Ansink A.C., Vergote I., et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol 2010, 11(7):646-652.
13. de Hullu J.A., Doting E., Piers D.A., Hollema H., Aalders J.G., Koops H.S., et al. Sentinel lymph node identification with technetium-99m-labeled nanocolloid in squamous cell cancer of the vulva. J Nucl Med 1998, 39(8):1381-1385.
14. de Hullu J.A., Hollema H., Piers D.A., Verheijen R.H., van Diest P.J., Mourits M.J., et al. Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 2000, 18(15):2811-2816.
15. Hampl M., Hantschmann P., Michels W., Hillemanns P. Validation of the accuracy of the sentinel lymph node procedure in patients with vulvar cancer: results of a multicenter study in Germany. Gynecol Oncol 2008, 111(2):282-288.
16. Hauspy J., Beiner M., Harley I., Ehrlich L., Rasty G., Covens A. Sentinel lymph node in vulvar cancer. Cancer 2007, 110(5):1015-1023.
17. Levenback C., Coleman R.L., Burke T.W., Bodurka-Bevers D., Wolf J.K., Gershenson D.M. Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol 2001, 83(2):276-281.
18. Ansink A.C., Sie-Go D.M., van der Velden J., Sijmons E.A., de Barros Lopes A., Monaghan J.M., et al. Identification of sentinel lymph nodes in vulvar carcinoma patients with the aid of a patent blue V injection: a multicenter study. Cancer 1999, 86(4):652-656.
19. Van der Zee A.G., Oonk M.H., De Hullu J.A., Ansink A.C., Vergote I., Verheijen R.H., et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008, 26(6):884-889.
20. Terada K.Y., Shimizu D.M., Jiang C.S., Wong J.H. Outcomes for patients with T1 squamous cell cancer of the vulva undergoing sentinel node biopsy. Gynecol Oncol 2006, 102(2):200-203.
21. Moore R.G., Robison K., Brown A.K., DiSilvestro P., Steinhoff M., Noto R., et al. Isolated sentinel lymph node dissection with conservative management in patients with squamous cell carcinoma of the vulva: a prospective trial. Gynecol Oncol 2008, 109(1):65-70.
22. Devaja O., Mehra G., Coutts M., Adamson S., Montalto S.A., Donaldson J., et al. A prospective study of sentinel lymph node detection in vulval carcinoma: is it time for a change in clinical practice?. Int J Gynecol Cancer 2011, 12(3):559-564.
23. Merino G.A. Aplicabilidad de la tecmca de deteccion y biopsia del ganglio centinela en el cancer de vulva 2009, avalia-t, Santiago de Compostela, Available at:, accessed September 11, 2012. http://www.sergas.es/gal/Publicaciones/Docs/avalia-t/PDF-1895-ga.pdf.
24. Hailey D. INAHTA: a checklist for health technology assessment reports. Stockholm: INAHTA- International Network of Agencies for Health Technology Assessment 2007.
25. McGee J., Covens A. State of the art of sentinel lymph node biopsy in vulvar carcinoma. Womens Health 2009, 5(5):555-563.
26. Oonk M.H., van de Nieuwenhof H.P., van der Zee A.G., de Hullu J.A. Update on the sentinel lymph node procedure in vulvar cancer. Expert Rev Anticancer Ther 2010, 10(1):61-69.
27. Morton D.L., Wen D.R., Wong J.H., Economou J.S., Cagle L.A., Storm F.K., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992, 127(4):392-399.
28. Khan K. Sentinel lymph node (SLN) status in vulval cancer: systematic quantitative reviews and decision analytic model based economic evaluation. Health Technology Assessment 2011, NHS National Institute for Health Research, London.
29. Judson P.L., Jonson A.L., Paley P.J., Bliss R.L., Murray K.P., Downs L.S., et al. A prospective, randomized study analyzing sartorius transposition following inguinal-femoral lymphadenectomy. Gynecol Oncol 2004, 94(1):226-230.
30. Carlson J.W., Kauderer J., Walker J.L., Gold M.A., O'Malley D., Tuller E., et al. A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study. Gynecol Oncol 2008, 110(1):76-82.
31. Manci N., Marchetti C., Esposito F., De Falco C., Bellati F., Giorgini M., et al. Inguinofemoral lymphadenectomy: randomized trial comparing inguinal skin access above or below the inguinal ligament. Ann Surg Oncol 2009, 16(3):721-728.
32. Sawan S., Mugnai R., Lopes Ade B., Hughes A., Edmondson R.J. Lower-limb lymphedema and vulval cancer: feasibility of prophylactic compression garments and validation of leg volume measurement. Int J Gynecol Cancer 2009, 19(9):1649-1654.
33. Echt M.L., Finan M.A., Hoffman M.S., Kline R.C., Roberts W.S., Fiorica J.V. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South Med J 1999, 92(2):204-208.
34. Decesare S.L., Fiorica J.V., Roberts W.S., Reintgen D., Arango H., Hoffman M.S., et al. A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol Oncol 1997, 66(3):425-428.
35. Bowles J., Terada K.Y., Coel M.N., Wong J.H. Preoperative lymphoscintigraphy in the evaluation of squamous cell cancer of the vulva. Clin Nucl Med 1999, 24(4):235-238.
36. Sideri M., De Cicco C., Maggioni A., Colombo N., Bocciolone L., Trifiro G., et al. Detection of sentinel nodes by lymphoscintigraphy and gamma probe guided surgery in vulvar neoplasia. Tumori 2000, 86(4):359-363.
37. Boran N., Kayikcioglu F., Kir M. Sentinel lymph node procedure in early vulvar cancer. Gynecol Oncol 2003, 90(2):492-493.
38. Merisio C., Berretta R., Gualdi M., Pultrone D.C., Anfuso S., Agnese G., et al. Radioguided sentinel lymph node detection in vulvar cancer. Int J Gynecol Cancer 2005, 15(3):493-497.
39. Trifiro G., Travaini L.L., Sanvito F., Pacifici M., Mallia A., Ferrari M.E., et al. Sentinel node detection by lymphoscintigraphy and sentinellymph node biopsy in vulvar melanoma. Eur J Nucl Med Mol Imaging 2010, 37(4):736-741.
40. Klar M., Bossart M., Stickeler E., Brink I., Orlowska-Volk M., Denschlag D. Sentinel lymph node detection in patients with vulvar carcinoma; feasibility of intra-operative mapping with technetium-99m-labeled nanocolloid. Eur J Surg Oncol 2011, 37(9):818-823.
41. Molpus K.L., Kelley M.C., Johnson J.E., Martin W.H., Jones H.W. Sentinel lymph node detection and microstaging in vulvar carcinoma. J Reprod Med 2001, 46(10):863-869.
42. Tavares M.G., Sapienza M.T., Galeb N.A., Belfort F.A., Costa R.R., Osorio C.A., et al. The use of 99mTc-phytate for sentinel node mapping in melanoma, breast cancer and vulvar cancer: a study of 100 cases. Eur J Nucl Med 2001, 28(11):1597-1604.
43. Sliutz G., Reinthaller A., Lantzsch T., Mende T., Sinzinger H., Kainz C., et al. Lymphatic mapping of sentinel nodes in early vulvar cancer. Gynecol Oncol 2002, 84(3):449-452.
44. Moore R.G., DePasquale S.E., Steinhoff M.M., Gajewski W., Steller M., Noto R., et al. Sentinel node identification and the ability to detect metastatic tumor to inguinal lymph nodes in squamous cell cancer of the vulva. Gynecol Oncol 2003, 89(3):475-479.
45. Puig-Tintore L.M., Ordi J., Vidal-Sicart S., Lejarcegui J.A., Torne A., Pahisa J., et al. Further data on the usefulness of sentinel lymph node identification and ultrastaging in vulvar squamous cell carcinoma. Gynecol Oncol 2003, 88(1):29-34.
46. Radziszewski J., Panek G., Bidzinski M., Sobiczewski P., Derlatka P., Nasierowska-Guttmejer A., et al. Sentinel lymph node in vulvar cancer- a pilot study to identify and assess the diagnostic value. Nowotwory 2003, 53(3):270-274.
47. Basta A., Pitynski K., Basta P., Hubaiewska-Hola A., Oplawski M., Przeszlakowski D. Sentinel node in gynaecological oncology. Rep Pract Oncol Radiother 2005, 10(2):91-94.
48. Louis-Sylvestre C., Evangelista E., Leonard F., Itti E., Meignan M., Paniel B.J. Sentinel node localization should be interpreted with caution in midline vulvar cancer. Gynecol Oncol 2005, 97(1):151-154.
49. Wydra D., Sawicki S., Emerich J., Romanowicz G. Evaluation of sentinel node detection in vulvar cancer. Nucl Med Rev Cent East Eur 2005, 8(2):128-130.
50. Martinez-Palones J.M., Perez-Benavente M.A., Gil-Moreno A., Diaz-Feijoo B., Roca I., Garcia-Jimenez A., et al. Comparison of recurrence after vulvectomy and lymphadenectomy with and without sentinel node biopsy in early stage vulvar cancer. Gynecol Oncol 2006, 103(3):865-870.
51. Nyberg R.H., Iivonen M., Parkkinen J., Kuoppala T., Maenpaa J.U. Sentinel node and vulvar cancer: a series of 47 patients. Acta Obstet Gynecol Scand 2007, 86(5):615-619.
52. Rob L., Robova H., Pluta M., Strnad P., Kacirek J., Skapa P., et al. Further data on sentinel lymph node mapping in vulvar cancer by blue dye and radiocolloid Tc99. Int J Gynecol Cancer 2007, 17(1):147-153.
53. Vidal-Sicart S., Puig-Tintore L.M., Lejarcegui J.A., Paredes P., Ortega M.L., Munoz A., et al. Validation and application of the sentinel lymph node concept in malignant vulvar tumours. Eur J Nucl Med Mol Imaging 2007, 34(3):384-391.
54. Johann S., Klaeser B., Krause T., Mueller M.D. Comparison of outcomeand recurrence-free survival after sentinel lymph node biopsy andlymphadenectomy in vulvar cancer. Gynecol Oncol 2008, 110(3):324-328.
55. Achimas-Cadariu P., Harter P., Fisseler-Eckhoff A., Beutel B., Traut A., Du Bois A. Assessment of the sentinel lymph node in patients with invasive squamous carcinoma of the vulva. Acta Obstet Gynecol Scand 2009, 88(11):1209-1214.
56. Camara O., Gonnert H., Herrmann J., Egbe A., Diebolder H., Gajda M., et al. Sentinel lymph node biopsy in vulvar cancer: a pilot study. Eur J Gynaecol Oncol 2009, 30(6):622-624.
57. Klat J., Sevcik L., Simetka O., Graf P., Waloschek T., Kraft O., et al. Characteristics of sentinel lymph nodes' metastatic involvement in early stage of vulvar cancer. Aus N Z J Obstet Gynaecol 2009, 49(6):672-676.
58. Levenback C.F., Tian C., Coleman R.L., Gold M.A., Fowler J.M., Judson P.L. Sentinel node (SN) biopsy in patients with vulvar cancer: a Gynecologic Oncology Group (GOG) study. J Clin Oncol 2009, 27:5505. (15S; May 20 Suppl).
59. Lindell G., Jonsson C., Ehrsson R.J., Jacobsson H., Danielsson K.G., Kallstrom B.N., et al. Evaluation of preoperative lymphoscintigraphy and sentinel node procedure in vulvar cancer. Eur J Obstet Gynecol Reprod Biol 2010, 15(1):91-95.
60. Radziszewski J., Kowalewska M., Jedrzejczak T., Kozlowicz-Gudzinska I., Nasierowska-Guttmejer A., Bidzinski M., et al. The accuracy of the sentinel lymph node concept in early stage squamous cell vulvar carcinoma. Gynecol Oncol 2010, 116(3):473-477.
61. Sawicki S., Romanowicz G., Wydra D., Lass P. The usefulness of sentinel lymph node detection in vulvar cancer-a short communication. Nucl Med Rev Cent East Eur 2010, 13(2):81-83.
62. Crane L.M., Themelis G., Arts H.J., Buddingh K.T., Brouwers A.H., Ntziachristos V., et al. Intraoperative near-infrared fluorescence imaging for sentinel lymph node detection in vulvar cancer: first clinical results. Gynecol Oncol 2011, 120(2):291-295.
63. Levenback C.F., van der Zee A.G., Rob L., Plante M., Covens A., Schneider A., et al. Sentinel lymph node biopsy in patients with gynecologic cancers Expert panel statement from the International Sentinel Node Society Meeting, February 21, 2008. Gynecol Oncol 2009, 114(2):151-156.
64. Rodier J.F., Janser J.C., Routiot T., David E., Ott G., Schneegans O., et al. Sentinel node biopsy in vulvar malignancies: a preliminary feasibility study. Oncol Rep 1999, 6(6):1249-1252.
65. de Hullu J.A., Hollema H., Hoekstra H.J., Piers D.A., Mourits M.J., Aalders J.G., et al. Vulvar melanoma: is there a role for sentinel lymph node biopsy?. Cancer 2002, 94(2):486-491.
66. Vakselj A., Bebar S. The role of sentinel lymph node detection in vulvar carcinoma and the experiences at the Institute of Oncology Ljubljana. Radiol Oncol 2007, 41(4):167-173.
67. Hefler L.A., Grimm C., Six L., Seebacher V., Polterauer S., Joura E., et al. Inguinal sentinel lymph node dissection vs. complete inguinal lymph node dissection in patients with vulvar cancer. Anticancer Res 2008, 28(1):515-517.
68. Stehman F.B., Bundy B.N., Dvoretsky P.M., Creasman W.T. Early stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet Gynecol 1992, 79(4):490-497.
69. Burke T.W., Levenback C., Coleman R.L., Morris M., Silva E.G., Gershenson D.M. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol Oncol 1995, 57(2):215-220.
70. Gori J.R., Fritsches H.W., Castano R., Toziano M., Habich D. Ipsilateral superficial inguinal lymphadenectomy for the treatment of early cancer of the vulva. J Low Genit Tract Dis 2002, 6(3):150-154.
71. Gordinier M.E., Malpica A., Burke T.W., Bodurka D.C., Wolf J.K., Jhingran A., et al. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol Oncol 2003, 90(3):625-628.
72. Frumovitz M., Ramirez P.T., Tortolero-Luna G., Malpica A., Eifel P., Burke T.W., et al. Characteristics of recurrence in patients who underwent lymphatic mapping for vulvar cancer. Gynecol Oncol 2004, 92(1):205-210.
73. Kirby T.O., Rocconi R.P., Numnum T.M., Kendrick J.E., Wright J., Fowler W., et al. Outcomes of stage I/II vulvar cancer patients after negative superficial inguinal lymphadenectomy. Gynecol Oncol 2005, 98(2):309-312.
74. Woolderink J.M., de Bock G.H., de Hullu J.A., Davy M.J., van der Zee A.G., Mourits M.J. Patterns and frequency of recurrences of squamous cell carcinoma of the vulva. Gynecol Oncol 2006, 103(1):293-299.
75. Bell J.G., Lea J.S., Reid G.C. Complete groin lymphadenectomy with preservation of the fascia lata in the treatment of vulvar carcinoma. Gynecol Oncol 2000, 77(2):314-318.
76. Gonzalez Bosquet J., Magrina J.F., Gaffey T.A., Hernandez J.L., Webb M.J., Cliby W.A., et al. Long-term survival and disease recurrence in patients with primary squamous cell carcinoma of the vulva. Gynecol Oncol 2005, 97(3):828-833.
77. Butler J.S., Milliken D.A., Dina R., Eccles S.A., Maghami S.G., Jameson C., et al. Isolated groin recurrence in vulval squamous cell cancer (VSCC). The importance of node count. Eur J Gynaecol Oncol 2010, 31(5):510-513.
78. Katz A., Eifel P.J., Jhingran A., Levenback C.F. The role of radiation therapy in preventing regional recurrences of invasive squamous cell carcinoma of the vulva. Int J Radiat Oncol Biol Phys 2003, 57(2):409-418.
79. Sznurkowski J.J., Emerich J. Characteristic features of recurrences of squamous cell carcinoma of the vulva. Ginekol Pol 2010, 81(1):12-19.
80. Helm C.W., Hatch K., Austin J.M., Partridge E.E., Soong S.J., Elder J.E., et al. A matched comparison of single and triple incision techniques for the surgical treatment of carcinoma of the vulva. Gynecol Oncol 1992, 46(2):150-156.
81. Lin J.Y., Du Beshter B., Angel C., Dvoretsky P.M. Morbidity and recurrence with modifications of radical vulvectomy and groin dissection. Gynecol Oncol 1992, 47(1):80-86.
82. Rouzier R., Haddad B., Dubernard G., Dubois P., Paniel B.J. Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival. J Am Coll Surg 2003, 196(3):442-450.
83. Grimshaw R.N., Murdoch J.B., Monaghan J.M. Radical vulvectomy and bilateral inguinal-femoral lymphadenectomy through separate incisions-experience with 100 cases. Int J Gynecol Cancer 1993, 3(1):18-23.
84. Zhang S.H., Sood A.K., Sorosky J.I., Anderson B., Buller R.E. Preservation of the saphenous vein during inguinal lymphadenectomy decreases morbidity in patients with carcinoma of the vulva. Cancer 2000, 89(7):1520-1525.
85. Gould N., Kamelle S., Tillmanns T., Scribner D., Gold M., Walker J., et al. Predictors of complications after inguinal lymphadenectomy. Gynecol Oncol 2001, 82(2):329-332.
86. Zhang X., Sheng X., Niu J., Li H., Li D., Tang L., et al. Sparing of saphenous vein during inguinal lymphadenectomy for vulval malignancies. Gynecol Oncol 2007, 105(3):722-726.
87. Magrina J.F., Gonzalez-Bosquet J., Weaver A.L., Gaffey T.A., Webb M.J., Podratz K.C., et al. Primary squamous cell cancer of the vulva: radical versus modified radical vulvar surgery. Gynecol Oncol 1998, 71(1):116-121.
88. Leminen A., Forss M., Paavonen J. Wound complications in patients with carcinoma of the vulva: comparison between radical and modified vulvectomies. Eur J Obstet Gynecol Reprod Biol 2000, 93(2):193-197.
89. Dardarian T.S., Gray H.J., Morgan M.A., Rubin S.C., Randall T.C. Saphenous vein sparing during inguinal lymphadenectomy to reduce morbidity in patients with vulvar carcinoma. Gynecol Oncol 2006, 101(1):140-142.
90. Abbas S., Seitz M. Systematic review and meta-analysis of the used surgical techniques to reduce leg lymphedema following radical inguinal nodes dissection. Surg Oncol 2011, 20(2):88-96.
91. de Kok I., Habbema J., van Rosmalen J., van Ballegooijen M. Would the effect of HPV vaccination on non-cervical HPV-positive cancers make the difference for its cost-effectiveness?. Eur J Cancer 2011, 47(3):428-435.
92. Insinga R., Ye X., Singhal P., Carides G. Healthcare resource use and costs associated with cervical, vaginal and vulvar cancers in a large U.S. health plan. Gynecol Oncol 2008, 111(2):188-196.
93. Jacobs P., Bachynsky J. An Alberta standard cost list for health economics evaluations 2005, Institute of Health Economics, Alberta.
94. Uyl-De Groot C.A., Hartog J.G., Derksen J.G., Symons E.A., Buijt I., van der Velden J., et al. Cost-effectiveness and quality of life of granulocyte-colony stimulating factor (filgrastim) after radical vulvectomy and bilateral inguino-femoral lymphadenectomy: results of a randomized clinical trial. Eur J Obstet Gynecol Reprod Biol 2004, 114(1):77-82.
95. Robison K., Steinhoff M.M., Granai C.O., Brard L., Gajewski W., Moore R.G. Inguinal sentinel node dissection versus standard inguinal node dissection in patients with vulvar cancer: a comparison of the size of metastasis detected in inguinal lymph nodes. Gynecol Oncol 2006, 101(1):24-27.
96. Oonk M.H., van de Nieuwenhof H.P., de Hullu J.A., van der Zee A.G. The role of sentinel node biopsy in gynecological cancer: a review. Curr Opin Oncol 2009, 21(5):425-432.
97. de Hullu J.A., Oonk M.H., Ansink A.C., Hollema H., Jager P.L., van der Zee A.G. Pitfalls in the sentinel lymph node procedure in vulvar cancer. Gynecol Oncol 2004, 94(1):10-15.
98. Plante M., Renaud M.C., Roy M. Sentinel node evaluation in gynecologic cancer. Oncology (Williston Park) 2004, 18(1):75-87. discussion 88-90.
99. Brunner A.H., Polterauer S., Tempfer C., Joura E., Reinthaller A., Horvat R., et al. The accuracy of intraoperative frozen section of the inguinal sentinel lymph node in vulvar cancer. Anticancer Res 2008, 28(6):4091-4094.
100. Moore R.G., Granai C.O., Gajewski W., Gordinier M., Steinhoff M.M. Pathologic evaluation of inguinal sentinel lymph nodes in vulvar cancer patients: a comparison of immunohistochemical staining versus ultrastaging with hematoxylin and eosin staining. Gynecol Oncol 2003, 91(2):378-382.
101. Hakam A., Nasir A., Raghuwanshi R., Smith P.V., Crawley S., Kaiser H.E., et al. Value of multilevel sectioning for improved detection of micrometastases in sentinel lymph nodes in invasive squamous cell carcinoma of the vulva. Anticancer Res 2004, 24(2):1281-1286.
102. Baker P., Oliva E. A practical approach to intraoperative consultation in gynecological pathology. Int J Gynecol Pathol 2008, 27(3):353-365.
103. Knopp S., Holm R., Trope C., Nesland J.M. Occult lymph node metastases in early stage vulvar carcinoma patients. Gynecol Oncol 2005, 99(2):383-387.
104. Janda M., Obermair A., Cella D., Crandon A.J., Trimmel M. Vulvar cancer patients' quality of life: a qualitative assessment. Int J Gynecol Cancer 2004, 14(5):875-881.
105. Oonk M.H., van Os M.A., de Bock G.H., de Hullu J.A., Ansink A.C., van der Zee A.G. A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy. Gynecol Oncol 2009, 113(3):301-305.
106. de Hullu J.A., Ansink A.C., Tymstra T., van der Zee A.G. What doctors and patients think about false-negative sentinel lymph nodes in vulvar cancer. J Psychosom Obstet Gynecol 2001, 22(4):199-203.
107. Wenzel L. Patient-reported outcomes in sentinel lymph node procedure versus inguinofemoral lymphadenectomy: what is the next step?. Gynecol Oncol 2009, 113(3):299-300.
108. Terada K.Y., Shimizu D.M., Wong J.H. Sentinel node dissection and ultrastaging in squamous cell cancer of the vulva. Gynecol Oncol 2000, 76(1):40-44.
109. Kim T., Giuliano A.E., Lyman G.H. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma: a metaanalysis. Cancer 2006, 106(1):4-16.
110. Levenback C., Burke T.W., Morris M., Malpica A., Lucas K.R., Gershenson D.M. Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol 1995, 59(2):216-220.